Div28

2015-09-17

[#DIV28SUPER] Postdoc in neuroimaging at Auburn University

Attached is an announcement of a postdoctoral fellowship in neuroimaging on a 3T and 7T imager. Please forward to people who might be interested.

. . . Chris

From: Jeffrey Katz
Sent: Wednesday, September 16, 2015 1:38 PM
To: Chris Newland <newlamc@auburn.edu>
Subject: Post Doc Ad

Hi Chris,

Attached is the Post doc ad. Can you circulate on the APA Div 25 and 28 please.

Best,

Jeff

2015-09-16

[#DIV28SUPER] 3rd ANNUAL VERMONT CENTER ON BEHAVIOR & HEALTH CONFERENCE

On behalf of Marissa Wells
PLEASE CIRCULATE:

3rd Annual Conference:
Behavior Change, Health, and Health Disparities

October 1-2, 2015
Burlington, Vermont

Not able to attend the VCBH Conference in person? You can livestream the lectures from your laptop!

See the conference agenda on our website and use this link to tune in, Oct 1-2, starting at 8 a.m.

--
Marissa Wells
Research Staff Assistant
Vermont Center on Behavior and Health
University of Vermont
802.656.0079

http://www.uvm.edu/medicine/behaviorandhealth

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

2015-09-14

[#DIV28SUPER] Collaborative Perspectives on Addiction: Symposium Proposals Deadline Less than 2 Weeks Away!

Hello,

The deadline for symposium proposals for the 4th Annual Collaborative Perspectives of Addiction (CPA) meeting is now less than 2 weeks away! The meeting will take place in San Diego CA on March 18-19, 2016.

The deadline is a week from this Friday, September 25th, 2015.

For more information and to submit your proposal, please go to http://research.alcoholstudies.rutgers.edu/cpa

If you are interested in advertising for an open position or for another purpose at CPA, then we offer affordable advertising options in the conference program. http://research.alcoholstudies.rutgers.edu/cpa/sponsorship

We hope to see you all there!

[#DIV28SUPER] NIDA Neuroscience Update, September 14, 2015

Table of Contents:

I. FREE REGISTRATION IS OPEN! Frontiers in Addiction Research: 2015 Joint NIDA-NIAAA Mini-Convention Friday, October 16, 2015 8am - 5pm, McCormick Place Convention Center, N230, Chicago, IL http://apps1.seiservices.com/nida-niaaa/frontiers2015/Default.aspx

II. FOA: Tools for Monitoring and Manipulating Modified RNAs in the Nervous System

III. Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1) RFA-DA-16-007 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-007.html

IV. Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01) PAR-15-120 http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

---------------

I. Frontiers in Addiction Research: 2015 Joint NIDA-NIAAA Mini-Convention Friday, October 16, 2015 8am - 5pm, McCormick Place Convention Center, N230, Chicago, IL http://apps1.seiservices.com/nida-niaaa/frontiers2015/Default.aspx

Registration is open—Please register today to reserve your seat! The National Institute on Drug Abuse [NIDA] and the National Institute on Alcohol Abuse and Alcoholism [NIAAA] are pleased to present the annual Frontiers in Addiction Research [NIDA-NIAAA Mini-Convention] program, a satellite event of the Society for Neuroscience (SfN) Annual Meeting.

For more information about the agenda and registration click http://apps1.seiservices.com/nida-niaaa/frontiers2015/Default.aspx

For additional information on the logistics of the 2015 NIDA-NIAAA Mini-Convention, please contact Caitlin Dudevoir of Synergy Enterprises, Inc. at cdudevoir@seiservices.com.

II. FOA: Tools for Monitoring and Manipulating Modified RNAs in the Nervous System

RFA-DA-16-005, SBIR, R43/R44 mechanism

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-005.html

RFA-DA-16-006, STTR, R41/R42 mechanism,

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-006.html

Purpose: incentivize small businesses to generate tools, technologies, and products for monitoring and manipulating covalently modified eukaryotic RNA, including messenger RNA and regulatory RNA. In the long term, it is hoped that these tools and products will serve as the foundation for future NIDA-relevant research into the molecular mechanisms of substance abuse disorders.

Receipt date: Mid-November, 2015.

Set aside: $2M to fund a total of 5-8 awards for both RFAs.

Budget: Up to $150,000 total costs per year for Phase I and up to $1,000,000 total costs per year for Phase II may be requested.

SBIR or STTR? If the innovative tool to be commercialized will be developed via a partnership of ideas between a small business and an academic/non-profit research institution, consider applying using the STTR mechanism (R41/R42). Small businesses interested in the development of relevant innovative technologies are encouraged to apply via the SBIR mechanism (R43/R44).

Questions: Please contract Kris Bough (boughk@mail.nih.gov) for questions regarding the details of the SBIR/STTR mechanisms. Please contact John Satterlee (satterleej@nida.nih.gov) for scientific questions regarding RNA modifications.

III. Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1) RFA-DA-16-007

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-007.html

Application Due dates: October 20, 2015 and October 20, 2016, by 5:00 PM local time of applicant organization

Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.

The Genetics or Epigenetics of Substance Abuse Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics.

Contact:

Jonathan D. Pollock, Ph.D.

Chief

Genetics and Molecular Neurobiology Research Branch

Division of Basic Neurobiology and Behavioral Research

National Institute on Drug Abuse, NIH

6001 Executive Blvd, Rm. 4257

Bethesda, MD 20892

Tel. 301-435-1309

Email. jpollock@mail.nih.gov

Next application due date: Oct. 20, 2015

The goals of this initiative are to identify gene variants of traits associated with addiction and substance abuse in selectively bred, and outbred non-human animal models using methodologies of Next Gen-Sequencing, mapping, and genotyping. See more information at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

Contact:

Jonathan D. Pollock, Ph.D.

Chief

Genetics and Molecular Neurobiology Research Branch

Division of Basic Neurobiology and Behavioral Research

National Institute on Drug Abuse, NIH

6001 Executive Blvd, Rm. 4257

Bethesda, MD 20892

Tel. 301-435-1309

Email. jpollock@mail.nih.gov

--------------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contactjpollock@mail.nih.gov 301-435-1309

2015-09-12

[#DIV28SUPER] Fwd: Division 19 September, 2015 column

Pat DeLeon, an APA past president, writes to Div 19, the Society for Military Psychology about better care for military families, prescription privileges and several issues subsequent to the Hoffman report...

Begin forwarded message:

From: "Pat DeLeon" <patdeleon@verizon.net>
Date: September 12, 2015 at 8:47:39 AM EDT
...

TORONTO – HOME OF THE HOCKEY HALL OF FAME
            The 123^rd APA annual convention was exciting and Toronto is a beautiful city. There were a number of very interesting symposia highlighting, for example, the unique needs of military families, and the increasing impact of technology on healthcare and education. A Sunday panel described the difficulties civilian researchers have in accessing military families, primarily due to barriers imposed by the Departments of Defense (DoD) and Veterans Affairs (VA). This reminded me of the Give an Hour event earlier in the year during which the highest levels of health leadership within those two agencies agreed that healthcare records must possess interoperability if only for "quality of care" reasons – the same policy position endorsed by the Congress and previous Departmental Secretaries – but which still remains unresolved. Why is it that as a nation we continue to tolerate DoD/VA providers maintaining separate silo-based systems? Give an Hour's keynote speaker – First Lady Michelle Obama – clearly put Wounded Warriors first in her talk and challenged the audience to join their Campaign to Change Direction. Yet, why is it the Society for Military Psychology and the VA psychology leadership still do not schedule regular meetings or collaborative programs? Their beneficiaries are essentially the same, just at different stages in their life journeys. Accordingly, on several occasions, I was particularly pleased to hear Division 19 President Tom Williams describe the importance of focusing upon the "bigger picture" and psychology's fundamental mission.
            When pioneers Commander John Sexton and Lt. Commander Morgan Sammons graduated from the DoD psychopharmacology training program on June 17, 1994, they created a vision for psychology that very few had ever foreseen. The military "established the legitimacy of a prescription-training program outside of traditional medical school, thus providing a strong answer to the traditional critique from psychiatrists...." The civilian sector has responded and in Toronto, Beth Rom-Rymer described the Illinois Psychological Association's RxP success; as well as her visionary efforts to engage graduate (and undergraduate) students in their training. Judi Steinman's training program is within a college of pharmacy, as APA Board member Linda Campbell had originally proposed and implemented for three years at the Georgia Psychological Association. And, Tony Puente provided an historical overview, having served on the original APA Task Force on Psychopharmacology whose 1992 report proffered "the proposed new providers had the potential to dramatically improve patient care and make important new advances in treatment."
            The Hoffman Report: APA's Past-President Nadine Kaslow and President-Elect Susan McDaniel were inspirational in chairing the Town Hall meeting addressing the Hoffman Report. The number of concerned colleagues who attended was most impressive, as was their genuine enthusiasm for fundamental reform. One might (or might not) agree with the view subsequently expressed in the national media by Anne Speckhard who described the sweeping ban on any involvement by psychologists in national security interrogations as a "knee-jerk" reaction that some members felt was sorely needed to restore APA's reputation. She reported that in 2006 and 2007, she worked in Iraq with Task Force 134 on a program to challenge ideologically committed Islamic extremists. The idea was to try to engage detainees who had been exposed to, or adhered to, militant jihadi ideology in order to redirect them to other, nonviolent solutions. She took extraordinary care to write the highest level of ethical care into her program, instilling in all she trained that prisoners must be treated with respect, care and dignity and not tricked or mistreated. For her, the ban is simply sidestepping responsibility for what APA failed to do, and still has not done, in regard to those who took part in harsh interrogations or witnessed and abetted "soft" torture or so-called enhanced interrogation techniques. In her view, those psychologists should have been, and should still be, called up on ethics charges and have their APA membership revoked. "Banning involvement in what the government is doing is simply refusing to take a stand for what is right." At the Toronto Town Hall meeting, the membership was definitely engaged which, in my judgment, speaks very well for the future of the profession.
            But for The Timing – Providing a Different Perspective: I was surprised when one of the participants at the Town Hall meeting received a standing ovation after stating he had over 500 signatures urging APA President Barry Anton to resign. For decades, Barry has been a visionary spokesperson on behalf of our nation's children and youth. He is a veteran and personally appreciates the many contributions that military and VA psychologists have made to our nation. Returning from the convention, I again carefully reviewed what the Hoffman Report actually said about his participation. I concluded that if I had been President in 2015, rather than 2000, there is little question that the same individuals would have been demanding my resignation. Having been involved in APA governance for nearly 25 years, I seriously doubt that I would have acted any differently than our then-APA Recording Secretary.
            The Report points out that Barry was involved in the selection of the 2005 PENS Task Force and as Board Liaison, participated in the Task Force meeting -- "but was involved substantially less than the others." From my perspective, he consistently was a voice of reason urging that all who might be concerned about the underlying issues be respectfully listened to and engaged. For example, when it was proposed that the Board of Directors should adopt the PENS report as policy, he stated: "I'm not sure it can go out as policy without [Council of Representatives] approval. The [Board] can certainly accept the report." Subsequently, when the Board declared an "emergency" – a step which, in retrospect, all agree was highly unusual – his efforts assured that the entire Board would appreciate the seriousness of their action. Similarly, in response to the 2008 member-driven Petition Resolution, he appropriately informed senior APA staff that "he had been hearing concerns from Council regarding the Board's instruction that the ballot be accompanied by pro and con statements." These are thoughtful responses which, in my judgement, were appropriate if not judicious. I sincerely hope that the perspective and clarity of thought demonstrated by Tom Williams will ultimately be embraced by the vast majority of APA. Aloha,
Pat DeLeon, former APA President – Division 19 – September, 2015

<D19-2015.09.docx>

2015-09-03

[#DIV28SUPER] Interprofessional Advanced Fellowship in Addiction Treatment VA San Diego Healthcare System

Could the following advertisement be distributed to Division 28 members?

Thanks so much!

Tamara Wall

Interprofessional Advanced Fellowship in Addiction Treatment

VA San Diego Healthcare System

The VA San Diego Healthcare System (VASDHS) is one of seven sites selected for a VA-funded Interprofessional Advanced Fellowship in Addiction Treatment. Our two-year advanced fellowship is recruiting clinical/counseling psychologists and physicians. Advanced Fellows must demonstrate interest in pursuing VA and/or academic careers with addiction treatment as a significant focus. Fellows will spend at least 75% of their time in educational experiences and clinical research in addiction treatment. No more than 25% of fellow effort shall be for non-educational clinical service. Research mentors hold appointments at VASDHS and/or the University of California, San Diego (UCSD). These include Drs. Tamara Wall and Scott Matthews (Co-Directors), Abigail Angkaw, Robert Anthenelli, Sandra Brown, Neal Doran, Eric Granholm, Igor Grant, Nick Mellos, Mark Myers, Sonya Norman, Carmen Pulido, Neil Richtand, Marc Schuckit, Andrea Spadoni, Susan Tapert, Steven Thorp, and Ryan Trim. Faculty research interests include comorbidity and treatment outcome research, tobacco-related research, brain imaging and neuropsychological sequelae, etiology and genetics of substance use disorders. Please see the UCSD, Department of Psychiatry website for research interests of individual faculty mentors as well as additional information about our affiliate.

Application: Please submit a letter of interest (maximum 2 pages), CV, and 3 letters of recommendation. The letter of interest should include: a brief summary of educational, clinical and research experiences relevant to addictions and a statement of career goals, including research mentor(s) with whom you might be interested in working. Materials should be submitted by email to vafellowship@ucsd.edu. The application deadline is December 21, 2015. Late applications will be considered only for positions that are not filled by applicants who applied by December 15th. Applicants should be available for an interview in early 2016. Other interview dates and phone interviews may be possible. Please contact Dr. Tamara Wall (Tamara.Wall@va.gov) with questions about the psychologist position or Dr. Scott Matthews (Scott.Matthews@va.gov) with questions about the physician position.

Qualifications: The following are required for psychologists: 1) completion of an APA-accredited doctorate in clinical or counseling psychology and an APA-accredited clinical psychology internship by September 1, 2015, and 2) U.S. citizenship. The following are required for physicians: 1) completion of an ACGME accredited residency program, 2) a full and unrestricted license to practice in the U.S. or any of its territories, 3) be board certified or eligible with demonstration of active pursuit of board certification, 4) U.S. citizenship, and 5) if a graduate of a foreign medical school, must have evidence of ECFMG certification.

San Diego enjoys a reputation for a highly desirable climate. The nearby ocean, mountains and deserts allow an unusually wide variety of year-round outdoor activities.

2015-09-01

[#DIV28SUPER] Postdoctoral Position -Behavioral Economics

A postdoctoral position is available in Addiction Research Recovery Research Center at the Virginia Tech Carilion Research Institute. The position will contribute to NIDA, NIAAA, NCI, and NIDDK funded research studies employing behavioral economics and neuro-economic approaches to address addiction and/or obesity and its treatment using both human laboratory and clinical trial methodologies. This position will have the opportunity to participate in studies using our Quit and Recovery Registry, employing neuro-modulatory (TMS) and fMRI technologies. Applicants should be interested in pursuing a career in addiction or obesity research, be an effective and productive writer, and have research training in clinical, experimental, cognitive psychology or related fields. Applicants must have completed a Ph.D. Translational research training and career development opportunities are provided as part of this position. The successful candidate will collaborate with a dynamic, productive federally funded, multi-disciplinary team of researchers. Women and minorities are strongly encouraged to apply. Applications will be reviewed on an ongoing basis. The position will be open until filled. Submit a letter of interest and curriculum vitae and referees to Warren K. Bickel, Ph.D. wkbickel@vtc.vt.edu

Warren K. Bickel, Ph.D.

Director,

Addiction Recovery Research Center,

Virginia Tech Carilion Research Institute

Professor of Psychology, Virginia Tech

Professor of Health Sciences, Virginia Tech

Professor of Psychiatry, Virginia Tech Carilion School of Medicine

Virginia Tech Carilion Research Institute
2 Riverside Circle
Roanoke, VA, 24016

Email: wkbickel@vt.edu
Tel: 540 526 2088

Fax: 540-985-3361

International Quit & Recovery Website:

https://quitandrecovery.org/